EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 12 June 2025

EFPIA response to the European Commission call for evidence on the EU Biotech Act

Read our submission here.

EFPIA strongly support the ambition to foster a world-class innovation environment for biotechnologies. To make the EU more competitive, we urge coordinated and urgent action across several areas.

Reinforce internationally competitive IP protection rules.
Simplify, speed up and harmonise the EU framework for clinical trials.
Establish a center of excellence for manufacturing innovation.
Modernise the EU regulatory ecosystem.
Unlock broader use of private investments.
Boost digitalisation for biotech development.

From Principle to Practice: Paving the Future Beyond Animal Testing
12 June 2025 - Kirsty Reid

Helping to shape a roadmap to phase out animal testing for chemical safety assessments Read more

Videos

The importance of clinical trials

Ensuring patients have access to the latest advances in medical innovation.

EFPIA's highlights at the Euractiv Health Policy Conference

With Roberta Savli, EFPIA Executive Director of Public Affair.

IHI Call Days - call 11
23 June 2025 (Virtual event)

The IHI Call Days for IHI call 11 will take place from 23 to 30 June 2025 online and will include sessions on the individual... Read more

EUDF: Increasing productivity, competitiveness and resilience by tackling the interplay between...
24 June 2025 (European Parliament, Brussels)

On 24 June, EUDF is hosting a policy-focused event in collaboration with MEP Ignazio Marino, to explore the vital connection... Read more

Recent publications

Almost 100 new medicine approvals tracked; new data gives clearest picture yet of delays for...
14 May 2025 (News & Events)

EFPIA also publishes first report aimed specifically as a catalyst for action to tackle inequalities faced by smaller... Read more

New data shows no shift in access to medicines for millions of Europeans
07 May 2025 (News & Events)

EFPIA says perennial state of medicines inequality requires rapid action from multiple partners to address numerous... Read more

What we are reading

EMA Annual Report 2024
On 10 June 2025 (EMA)

The report gives insights into the Agency’s strategic priorities and contributions to public and animal health in... Read more

Delivering regulatory impact from consortium-based projects
On 09 June 2025 (Nature)

Discover lessons learned that could help maximise the regulatory impact of consortium-based projects.

Going green: meet the projects boosting the environmental performance of the health sector
On 05 June 2025 (IHI)

IMI and IHI projects are tackling the environmental impacts of the sector, from the use of water, energy and raw... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu